Revolution Medicines issues $500M 0.50% convertible notes due 2033

Revolution Medicines, Inc.

Issued $500M 0.50% Convertible Senior Notes due 2033 under indenture with U.S. Bank Trust as trustee.
Initial conversion price ~$198.80/share (5.0302 shares per $1,000 principal).
Notes are senior unsecured, redeemable after May 2030 if stock >130% conversion price for 20 of 30 trading days.
Holders may convert before Feb 2033 only upon specified events; after that anytime until maturity.
Fundamental change triggers repurchase right at 100% principal plus accrued interest.

item 1.01item 2.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.